대한의생명과학회지 (Biomedical Science Letters)

  • 제26권2호
  • /
  • Pages.57-65
  • /
  • 2020
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지
DOI QR코드

DOI QR Code

Neuroprotective Effects of Scopoletin on Neuro-damage caused by Alcohol in Primary Hippocampal Neurons

  • Lee, Jina (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University) ;
  • Cho, Hyun-Jeong (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University)
  • 투고 : 2020.04.27
  • 심사 : 2020.06.04
  • 발행 : 2020.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Excessive drinking of alcohol is known to be one of the main causes of various neurological diseases, such as Alzheimer's disease. Scopoletin is known to have anti-inflammatory and antioxidative properties, and to protect nerve cells. This study examined whether scopoletin inhibits the alcohol-induced apoptosis of primary hippocampal neurons, and how scopoletin regulates several factors associated with the caspase-mediated pathway. To achieve this, the cell viability and apoptosis rate of primary hippocampal neurons were measured by Cell Counting Kit-8 and flow cytometry, respectively. Apoptosis-related protein expressions (Bax, Bid, caspase-3, caspase-9, and Poly (ADP-ribose) polymerase (PARP)) were analyzed by Western blotting, and the ANOVA method was used to confirm the significance of the measured results. As a result, scopoletin inhibited the expressions of alcohol-induced apoptosis and apoptosis-related proteins in primary hippocampal neurons. These results suggest that down-regulation of Bid, Bax, and cleaved caspase-9 expression induced by scopoletin down-regulates the expression of cleaved caspase-3, inhibits the expression of cleaved PARP, and finally, inhibits mitochondrial apoptotic pathways. The study suggests that scopoletin is worth developing as a candidate for neuroprotective agent.

키워드

참고문헌

  1. Baloyannis SJ. Mitochondrial alterations in alzheimer's disease. Journal of Alzheimer's Disease. 2006. 9: 119-126. https://doi.org/10.3233/JAD-2006-9204
  2. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R. Relative frequencies of alzheimer disease, lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of florida brain bank. Alzheimer Disease and Associated Disorders. 2002. 16: 203-212. https://doi.org/10.1097/00002093-200210000-00001
  3. Barnes DE, Yaffe K. The projected impact of risk factor reduction on alzheimer's disease prevalence. Lancet Neurology. 2011. 10: 819-828. https://doi.org/10.1016/S1474-4422(11)70072-2
  4. Bonthius DJ, West JR. Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure. Alcoholism: Clinical and Experimental Research. 1990. 14: 107-118. https://doi.org/10.1111/j.1530-0277.1990.tb00455.x
  5. Calissano P, Matrone C, Amadoro G. Apoptosis and in vitro alzheimer's disease neuronal models. Communicative & Integrative Biology. 2009. 2: 163-169. https://doi.org/10.4161/cib.7704
  6. Carpinella MC, Ferrayoli CG, Palacios SM. Antifungal synergistic effect of scopoletin, a hydroxycoumarin isolated from melia azedarach l. fruits. Journal of Agricultural and Food Chemistry. 2005. 53: 2922-2927. https://doi.org/10.1021/jf0482461
  7. Ciobica A, Padurariu M, Bild W, Stefanescu C. Cardiovascular risk factors as potential markers for mild cognitive impairment and alzheimer's disease. Psychiatria Danubina. 2011. 23: 340-346.
  8. Das SK, Vasudevan DM. Alcohol-induced oxidative stress. Life Sciences. 2007. 81: 177-187. https://doi.org/10.1016/j.lfs.2007.05.005
  9. Dickson DW. Apoptotic mechanisms in alzheimer neurofibrillary degeneration: cause or effect?. The Journal of Clinical Investigation. 2004. 114: 23-27. https://doi.org/10.1172/JCI22317
  10. Ding Z, Dai Y, Hao H, Pan R, Yao X, Wang Z. Anti-inflammatory effects of scopoletin and underlying mechanisms. Pharmaceutical Biology. 2008. 46: 854-860. https://doi.org/10.1080/13880200802367155
  11. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Progress in Neurobiology. 1998. 56: 385-431. https://doi.org/10.1016/S0301-0082(98)00032-X
  12. Fonseca ACRG, Proenca T, Resende R, Oliveira CR, Pereira CMF. Neuroprotective effects of statins in an in vitro model of alzheimer's disease. Journal of Alzheimer's Disease. 2009. 17: 503-517. https://doi.org/10.3233/JAD-2009-1067
  13. Gnonlonfin GJB, Sanni A, Brimer L. Review scopoletin - a coumarin phytoalexin with medicinal properties. Critical Reviews in Plant Sciences. 2012. 31: 47-56. https://doi.org/10.1080/07352689.2011.616039
  14. Han JY, Joo Y, Kim YS, Lee YK, Kim HJ, Cho GJ, Choi WS, Kang SS. Ethanol induces cell death by activating caspase-3 in the rat cerebral cortex. Molecules and Cells. 2005. 20: 189-195.
  15. Han X, Hu Y, Yang Z, Jiang L, Shi S, Li Y, Guo M, Wu H, Wan Y. Amyloid ${\beta}$-42 induces neuronal apoptosis by targeting mitochondria. Molecular Medicine Reports. 2017. 16: 4521-4528. https://doi.org/10.3892/mmr.2017.7203
  16. Hollands C, Bartolotti N, Lazarov O. Alzheiemr's disease and hippocampal adult neurogenesis; exploring shared mechanisms. Frontiers in Neuroscience. 2016. 10: 178.
  17. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J. Acetylcholinesterase accelerates assembly of amyloid-${\beta}$-peptides into alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron. 1996. 16: 881-891. https://doi.org/10.1016/S0896-6273(00)80108-7
  18. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang Z, Antuono P. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. The Lancet Neurology. 2008. 7: 812-826. https://doi.org/10.1016/S1474-4422(08)70169-8
  19. Kim S, Jeong H, Yang S, Choi S, Seo M, Yun Y, Choi Y, Baik S, Park J, Gwon A, Yang D, Lee C, Lee S, Park K, Jo D. Effects of chronic alcohol consumption on expression levels of app and $a{\beta}$-producing enzymes. BMB Reports. 2011. 44: 135-139. https://doi.org/10.5483/BMBRep.2011.44.2.135
  20. Li X, Cheng W, Li J, Guo X, Guo C, Meng X, Sun S, Wang L. Protective effect of estrogen on apoptosis in a cell culture model of parkinson's disease. Clinical and Investigative Medicine. 2008. 31: E258-E264.
  21. Mann K, Agartz I, Harper C, Shoaf S, Rawlings RR, Momenan R, Hommer DW, Pfefferbaum A, Sullivan EV, Anton RF, Drobes DJ, George MS, Bares R, Machulla HJ, Mundle G, Reimold M, Heinz A. Neuroimaging in alcoholism: ethanol and brain damage. Alcoholism: Clinical and Experimental Research. 2001. 25: 104S-109S. https://doi.org/10.1111/j.1530-0277.2001.tb02383.x
  22. Moreno-Jimenez EP, Flor-Garcia M, Terreros-Roncal J, Rabano A, Cafini F, Pallas-Bazarra N, Avila J, Llorens-Martin M. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with alzheimer's disease. Nature Medicine. 2019. 24: 554-560.
  23. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. Journal of Neuroscience. 2000. 20: 3214-3220. https://doi.org/10.1523/jneurosci.20-09-03214.2000
  24. Narasimhan KKS, Jayakumar D, Velusamy P, Srinivasan A, Mohan T, Ravi DB, Uthamaraman S, Sathyamoorthy YK, Rajasekaran NS, Periandavan K. Morinda citrifolia and its active principle scopoletin mitigate protein aggregation and neuronal apoptosis through augmenting the dj-1/nrf2/are signaling pathway. Oxidative Medicine and Cellular Longevity. 2019. 2019: 1-13.
  25. Narasimhan KKS, Paul L, Sathyamoorthy YK, Srinivasan A, Chakrapani LM, Singh A, Ravi DB, Krishnan TR, Velusamy P, Kaliappan K, Radhakrishnan R, Periandavan K. Amelioration of apoptotic events in the skeletal muscle of intra-nigrally rotenone-infused parkinsonian rats by morinda citrifolia - up-regulation of bcl-2 and blockage of cytochrome c release. Food & Function. 2016. 7: 922-937. https://doi.org/10.1039/c5fo00505a
  26. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and alzheimer's disease. Neuroscience Letters. 2010. 469: 6-10. https://doi.org/10.1016/j.neulet.2009.11.033
  27. Pandy V, Narasingam M, Kunasegaran T, Murugan DD, Mohamed Z. Effect of noni (morinda citrifolialinn.) fruit and its bioactive principles scopoletin and rutin on rat vas deferens contractility: an ex vivo study. The Scientific World Journal. 2014. 2014: 1-11.
  28. Rollinger JM, Hornick A, Langer T, Stuppner H, Prast H. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. Journal of Medicinal Chemistry. 2004. 47: 6248-6254. https://doi.org/10.1021/jm049655r
  29. Scuderi C, Stecca C, Bronzuoli MR, Rotili D, Valente S, Mai A, Steardo L. Sirtuin modulators control reactive gliosis in an in vitro model of alzheimer's disease. Frontiers in Pharmacology. 2014. 5:89. https://doi.org/10.3389/fphar.2014.00089
  30. Spires TL, Orne JD, Santacruz K, Pitstick R, Carlson GA, Ashe KH, Hyman BT. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Neurobiology. 2006. 168: 1598-1607.
  31. Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW. Activated caspase-3 expression in alzheimer's and aged control brain: correlation with alzheimer pathology. Brain Research. 2001. 898: 350-357. https://doi.org/10.1016/S0006-8993(01)02018-2
  32. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK. Intraneuronal alzheimer $a{\beta}42$ accumulates in multivesicular bodies and is associated with synaptic pathology. The American Journal of Pathology. 2002. 161: 1869-1879. https://doi.org/10.1016/S0002-9440(10)64463-X
  33. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, Tohyama M. Tumor necrosis factor induces bcl-2 and bcl-x expression through $nf{\kappa}b$ activation in primary hippocampal neurons. Journal of Biological Chemistry. 1999. 274: 8531-8538. https://doi.org/10.1074/jbc.274.13.8531
  34. Wilson RS, Segawa E, Boyle PA, Anagnos SE, Hizel LP, Bennett DA. The natural history of cognitive decline in alzheimer's disease. Psychology and Aging. 2012. 27: 1008-1017. https://doi.org/10.1037/a0029857
  35. Young C, Klocke BJ, Tenkova T, Choi J, Labruyere J, Qin Y, Holtzman DM, Roth KA, Olney JW. Ethanol-induced neuronal apoptosis in vivo requires bax in the developing mouse brain. Cell Death and Differentiation. 2003. 10: 1148-1155. https://doi.org/10.1038/sj.cdd.4401277
  36. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC. Correlates of hippocampal neuron number in alzheimer's disease and ischemic vascular dementia. Ann Neurol. 2005. 57: 896-903. https://doi.org/10.1002/ana.20503
  37. Zhao L, Wu T, Brinton RD. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased bcl-2 expression in primary hippocampal neurons. Brain Research. 2004. 1010: 22-34. https://doi.org/10.1016/j.brainres.2004.02.066
  38. Zhong J, Yang X, Yao W, Lee W. Lithium protects ethanol-induced neuronal apoptosis. Biochemical and Biophysical Research Communications. 2006. 305: 905-910. https://doi.org/10.1016/j.bbrc.2006.09.138